The study of ginsenoside Rg3 on the expression of vascular endothelial growth factors in ectopic endometrium of rats.

In: Chung-Hua Fu Ch'an K'o Tsa Chih · 2006 · W2379405443
article OA: closed CC0
View on OpenAlex

Abstract

Objective To observe the effect of ginsenoside Rg3 on the expression of vascular endothelial growth factors(VEGF) and antiangiogenesis in ectopic endometrium of rats. Methods Wistar rats endometriosis models were established referring to Jones methods, the model rats were divided into the control group, ginsenoside Rg3 group, gestrinone group, each group were divided into 2 weeks, 4 weeks, 6 weeks and 8 weeks. VEGF was observed in ectopic endometrium by immunohistochemistry (SABC technique). Results VEGF in ectopic endometrium were decreased remarkably after treatment of ginsenoside Rg3 after 2,4,6,8 weeks (P0. 05), while the difference was not significant (P0. 05) in the gestrinone group. And with the time prolonging, the expression of VEGF was reduced remarkably(P 0. 05) while the change was not observed in the control group and the gestrinone group. Conclusion Ginsenoside Rg3 has the effect on inhibiting the expression of VEGF and angiogenesis in ectopic endometrium of rats. Ginsenoside Rg3 maybe a new drug of antiangiogenesis in ectopic endometrium.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK